Tuberculosis, Multidrug-Resistant: all 132 studies
Page 1 of 2. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant TuberculosisNot yet recruitingNCT07675954Phase 3
- Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)RecruitingNCT07486024Phase 3
- Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis TreatmentRecruitingNCT07477119Phase 4
- Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)Not yet recruitingNCT07393438Phase 2
- Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese CohortNot yet recruitingNCT07268664Phase 3
- A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisRecruitingNCT07209761Phase 3
- Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa RegionRecruitingNCT07017803
- Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)Not yet recruitingNCT06674291
- Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant TuberculosisRecruitingNCT06590428Not applicable
- Program for Rifampicin-Resistant Disease With Stratified Medicine for TuberculosisRecruitingNCT06441006Phase 2/3
- Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary TuberculosisRecruitingNCT06224036Phase 2
- A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis PatientsRecruitingNCT05824871Phase 3
- Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB TreatmentRecruitingNCT05671718Not applicable
- An Adaptive Randomized Controlled TrialRecruitingNCT05633056Not applicable
- Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant TuberculosisRecruitingNCT05555303Phase 2
- Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant TuberculosisRecruitingNCT05553236Not applicable
- Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)RecruitingNCT05534750Phase 2
- A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TBRecruitingNCT05493267Phase 4
- A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in ChinaRecruitingNCT05306223Phase 4
- Bioneer Q-RFIA Clinical EvaluationRecruitingNCT05117788
- Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)RecruitingNCT05081401Phase 3
- Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in NamibiaRecruitingNCT05022238
- Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant TuberculosisNot yet recruitingNCT05007795Not applicable
- Novel Triple-dose Tuberculosis Retreatment RegimenRecruitingNCT04260477Phase 3
- Training Protocol on the Natural History of TuberculosisRecruitingNCT01212003
- Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary TuberculosisTerminatedNCT05971602Phase 2Results posted
- A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy AdultsCompletedNCT05526911Phase 1Results posted
- Linezolid Dosing Strategies in Drug-Resistant TBCompletedNCT05007821Phase 2Results posted
- Adjunctive Acetylsalicylic Acid and Ibuprofen for TuberculosisTerminatedNCT04575519Phase 2Results posted
- Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of PretomanidCompletedNCT04309656Phase 1Results posted
- A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary TuberculosisCompletedNCT04179500Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169CompletedNCT04150224Phase 1Results posted
- Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult PatientsCompletedNCT03338621Phase 2/3Results posted
- An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB TreatmentCompletedNCT03266003Not applicableResults posted
- Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant TuberculosisCompletedNCT03086486Phase 3Results posted
- Tuberculosis Research of INA-RESPOND On Drug ResistanceCompletedNCT02758236Results posted
- Treatment Shortening of MDR-TB Using Existing and New DrugsCompletedNCT02619994Phase 2Results posted
- A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683CompletedNCT02573350Phase 2Results posted
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT02409290Phase 3Results posted
- Shortening Treatment by Advancing Novel DrugsCompletedNCT02342886Phase 3Results posted
- A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TBCompletedNCT02333799Phase 3Results posted
- A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.CompletedNCT02193776Phase 2Results posted
- A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection OutcomesCompletedNCT02129244Not applicableResults posted
- Efficacy and Safety of Levofloxacin for the Treatment of MDR-TBCompletedNCT01918397Phase 2Results posted
- A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)CompletedNCT01859923Phase 2Results posted
- Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in GuangzhouCompletedNCT01618422Not applicableResults posted
- Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis PatientsCompletedNCT01521364Phase 4Results posted
- Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant TuberculosisCompletedNCT01424670Phase 3Results posted
- Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive TuberculosisTerminatedNCT01131351Phase 2Results posted
- To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.CompletedNCT00910871Phase 2Results posted
- Linezolid to Treat Extensively-Drug Resistant TuberculosisCompletedNCT00727844Phase 2Results posted
- A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)CompletedNCT00685360Phase 2Results posted
- TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TBCompletedNCT00664313Phase 1/2Results posted
- TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).CompletedNCT00449644Phase 2Results posted
- Metronidazole for Pulmonary Tuberculosis (South Korea)CompletedNCT00425113Phase 2Results posted
- Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical TrialCompletedNCT07058233Not applicable
- HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical OutcomesCompletedNCT06671808
- Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortActive, not recruitingNCT06649721Phase 3
- Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment RegimensActive, not recruitingNCT05871489
- A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TBCompletedNCT05278988Phase 4
- Triage Test for All Oral DR-TB Regimen (TRiAD Study)CompletedNCT05175794
- Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment TrialStatus unknownNCT05017324Not applicable
- PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant TuberculosisTerminatedNCT04783727Not applicable
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUSCompletedNCT04717908Not applicable
- Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy AdultsCompletedNCT04493671Phase 1
- MDR-TB Close Contacts Tracing in China (TCCT Study)Status unknownNCT04484129
- Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in ChinaStatus unknownNCT04421495Phase 4
- New Genomic Techniques and Management of Multidrug-resistant TuberculosisStatus unknownNCT04397536
- Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, IndiaCompletedNCT04342598
- Clinical Evaluation of tNGS for Diagnosis of DR-TBCompletedNCT04239326
- Artificial Inteligent for Diagnosing Drug-Resistant TuberculosisCompletedNCT04208789
- Economic Evaluation of New MDR TB RegimensCompletedNCT04207112Phase 2/3
- Evaluation of Centralised TB Assay SolutionsCompletedNCT04147676
- Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in TanzaniaCompletedNCT04124055Not applicable
- Behavior Change and Digital Health Interventions for Improved TB Treatment OutcomesCompletedNCT04119375Not applicable
- PRACTECAL-PKPD Sub StudyStatus unknownNCT04081077Phase 2/3
- Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of CareCompletedNCT04062201Phase 3
- Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical TrialCompletedNCT03942354
- Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)CompletedNCT03896685Phase 3
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)CompletedNCT03867136Phase 4
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT03830671Phase 4
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TBActive, not recruitingNCT03828201Phase 2
- Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB TuberculosisStatus unknownNCT03827811
- Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH CohortCompletedNCT03822156
- Xpert MTB/XDR Clinical Evaluation TrialCompletedNCT03728725
- NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TBStatus unknownNCT03604848Not applicable
- Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT CellsStatus unknownNCT03575299Phase 1
- Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsActive, not recruitingNCT03568383Phase 3
- A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in AlsaceStatus unknownNCT03507816
- Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TBCompletedNCT03470233
- Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis PatientsStatus unknownNCT03409315
- DIAgnostics for Multidrug Resistant Tuberculosis in AfricaCompletedNCT03303963
- Expand New Drugs for TB [endTB]CompletedNCT03259269
- The Individualized M(X) Drug-resistant TB Treatment Strategy StudyTerminatedNCT03237182Phase 4
- Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosisCompletedNCT03137875
- Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TBStatus unknownNCT03069534Phase 2/3
- Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug ResistanceCompletedNCT03057756
- PK of Levofloxacin in MDR-TB PatientsCompletedNCT03000517
- Line Probe Assay Evaluation StudyCompletedNCT02984579
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and LevofloxacinWithdrawnNCT02975570Phase 3